Gilboa David Abraham

Co-CEO David Abraham sold 80,094 shares of WRBY at $29.46 on 2026-01-13, reducing stake by 68.3% to 37,247 shares.

Gilboa David Abraham, Co-Chief Executive Officer, sold 80,094 shares at $29.46 on 2026-01-13, reducing his holdings from 117,341 shares to 37,247 shares—a 68.3% reduction in stake. The sale occurred near the 52-week high ($30.23), with the stock currently trading at $28.33, -6.3% from its peak. This represents a substantial decrease in Abraham's direct equity position despite the company's +15.2% annual revenue growth, though the company remains unprofitable on a full-year basis with a P/E of 2833.00. However, a derivative-conversion flag indicates this may reflect a conversion or reallocation of derivative securities rather than a pure exit from economic exposure. Notably, Abraham has executed five separate sales at WRBY in rapid succession (2025-12-11 through 2026-01-13), though none yet have measurable 90-day outcomes to assess timing accuracy.

Co-CEO Gilboa sold 94,906 shares at $27.51 avg (2 sales, $2.6M); retains 37,247 shares post-derivative conversion.

David Abraham, Co-Chief Executive Officer at Warby Parker, executed 2 separate sales totaling 94,906 shares for $2,610,815.54 between January 7–9, 2026 (blended average $27.51 per share). Following a derivative conversion, he retains 37,247 shares. The stock has declined 4.3% over the past 30 days and 6.4% from its 52-week high of $30.23, trading near that peak. Across his cross-ticker track record, Abraham's 20 prior sells have been well-timed at the 90-day mark 88.24% of the time, with an average 90-day return of -12.4%; his 2 prior measurable sales at WRBY specifically were also well-timed at the 90-day horizon. However, 3 of his 5 recent WRBY sales (2025-12-11, 2026-01-02, 2026-01-06) remain unmeasurable. The company's fundamentals show elevated valuation (P/E 2830) despite strong quarterly revenue of $221.7M and 15.2% annual growth, though the business remains unprofitable on a full-year basis. The pattern of near-calendar sales and strong historical timing merit monitoring as earnings unfold.

Co-CEO Gilboa David Abraham sold 75,000 WRBY shares (66.8% of holdings) for $1,776,000.00 across two transactions in early January.

Co-Chief Executive Officer Gilboa David Abraham executed 2 separate sales totaling 75,000 shares for $1,776,000.00 on 2026-01-02 and 2026-01-06, reducing his holdings from 112,247 to 37,247 shares (a 66.8% reduction). This is a material reduction in executive stake by the company's co-leader. Notably, his prior 4 measurable sales at WRBY showed a 3-of-4 well-timed pattern at the 90-day mark (with 90-day returns of -19.3%, -2.9%, -3.2%, and +7.4%), and the stock has appreciated 38.2% over the past 30 days to its current price of $25.94—above both his blended transaction average of $23.68 and well into its 52-week range. The DERIVATIVE-CONVERSION FLAG indicates this filing reflects a conversion event; the insider's actual total position includes Table II derivative holdings not yet reflected in the database, so this sale should not be interpreted as a complete liquidation but rather as a discrete reduction of a specific share batch during an apparent securities conversion.

WRBY Co-CEO Gilboa sold 200,000 shares ($6.0M) at $30.20; holds 37,247 post-sale. Stock now $26.84.

Co-CEO David Abraham Gilboa sold 200,000 shares at $30.20 on 2025-12-11, reducing his post-transaction holdings to 37,247 shares. The sale represents a material reduction in his WRBY exposure and occurred near the 52-week high of $30.23. At the same-ticker level, Gilboa has executed five prior sells at WRBY within the past four months, with only 1 of 2 measurable 90-day outcomes showing a well-timed result (the 2025-09-11 sale followed by +7.4% return, a miss). His cross-ticker track record shows a 70.59% well-timed rate on 20 prior sells with average 90-day return of -1.7%, but current WRBY outcomes are mixed: three recent sells (Sept-Oct 2025) have all experienced 30-day declines of -19.1% to -28.2%, suggesting some timing success, yet a July sale gained +9.4% in 30 days. Warby Parker's fundamentals show elevated valuation (P/E of 2684.00) despite modest profitability ($5.9M net income on $221.7M quarterly revenue) and company-level unprofitability in its most recent full fiscal year, creating a structural disconnect between operational performance and market price.

WRBY Co-CEO sold 125,000 shares (-79.2% of holdings) at $27.30; still holds 32,861 shares via derivatives.

Co-CEO Gilboa David Abraham executed a substantial open-market sale of 125,000 shares at $27.30 on 2025-10-01, totaling $3,412,500, reducing his directly-held shares from 157,861 to 32,861 (a -79.2% reduction). The trade occurred near the 52-week high of $28.56, with the stock now at $26.22. This timing aligns with his cross-ticker track record, which shows 73.33% well-timed sell execution across 20 prior sales. However, his recent same-ticker history at WRBY shows a rapid succession of three sales within 7 days (Sept 11, 17, 18) and two prior July sales; none of the latter have reached 90-day measurement windows yet, limiting visibility into execution quality at this specific ticker. The sale warrants attention given WRBY's unprofitable full-year financials ($-1.8M net income) and the large magnitude of the reduction, though the presence of derivative holdings not yet visible in our database means this does not represent a total exit from the company.

WRBY Co-CEO Gilboa sold 58,960 shares (64.2% reduction) for $1.6M across 2 days at $27.52–$27.58

Gilboa David Abraham, Co-Chief Executive Officer, executed 2 separate sales totaling 58,960 shares (59.0K shares) for $1,626,080.80 ($1.6M) on September 17–18, 2025, at prices of $27.52 and $27.58, reducing his holdings by 64.2% to 32,861 shares (32.9K shares). The sales occur as WRBY trades near its 52-week high of $28.48 (+0.0% from peak) following strong recent momentum (+7.2% over 30 days, +31.0% over 90 days), though the company remains unprofitable (net income $-1.8M in the latest quarter). His cross-ticker track record shows a 75.00% well-timed sell rate over 90-day periods, but only 1 of 1 prior WRBY-specific sales had a measurable 90-day outcome (which was well-timed, showing -8.7% return after sale). The filing includes a derivative-conversion component, meaning Table II securities are not yet reflected in our database, so the 32,861 post-transaction share count in Table I does not represent his total position. A significant reduction in equity exposure at a valuation near the 52-week high warrants monitoring of underlying operational context.

Co-CEO Gilboa David Abraham sold 41,040 shares (55.5% of holdings) at $27.53; stock now at $26.36

Co-Chief Executive Officer Gilboa David Abraham sold 41,040 shares at $27.53 on 2025-09-11, reducing his open-market holdings by 55.5% to 32,861 shares. This represents a substantial reduction, though the FLAG indicates a derivative-conversion transaction (Table II holdings not yet populated), so the reported Table I position does not represent his full economic stake. Notably, his prior five sales at WRBY show mixed timing outcomes: his two 90-day-measurable trades (2025-03-04) both resulted in negative returns (-32.7%, -10.3% and -31.3%, -8.5%), yielding 2 of 2 well-timed at the 90-day mark; his three most recent sales (July–September 2025) show strong positive 30-day returns (+9.4%, +13.0%, +8.7%) but lack 90-day outcome data. The company is unprofitable (net income $-1.8M in the latest quarter) despite annual revenue growth of +15.2%, and the stock is currently trading -7.2% from its 52-week high of $28.42. This sale warrants investor attention given the executive position, the magnitude of the reduction, and the company's unprofitable status, though the derivative-conversion context means the full position picture remains incomplete.

Co-CEO Gilboa sold 75,000 shares ($1.8M) in 2 transactions at avg $24.27; retains 28,475 shares.

Gilboa David Abraham, Co-Chief Executive Officer, executed 2 separate sales totaling 75,000 shares for $1,820,120.00 at a blended average price of $24.27 on 2025-07-18 and 2025-07-21. This reduction represents 72.5% of his pre-transaction holdings, leaving him with 28,475 shares post-transaction. At his same-ticker history at WRBY, 4 of 4 prior measurable sells (dating back to January 2025) were well-timed at the 90-day mark, suggesting a pattern of selling before declines. The company generated $223.8M in quarterly revenue with $3.5M net income but was unprofitable on a full-year basis, and the stock has recently rallied 13.1% over 30 days and 64.8% over 90 days. The size and timing of this sale—executed while the stock trades 13.5% below its 52-week high—alongside the insider's historical pattern of well-timed exits, warrants investor attention to whether similar market weakness may follow.

Co-CEO David Abraham sold 202,968 shares for $4.8M in 3 transactions on March 4; holdings reduced 89.4% to 24,089 shares post-conversion

Co-CEO Gilboa David Abraham executed three separate sales totaling 202,968 shares for $4,772,513.20 at a blended average price of $23.51 on March 4, 2025, reducing his holdings by 89.4% from 227,057 shares to 24,089 shares. This substantial reduction occurred as WRBY stock is trading -17.3% from its 52-week high and -14.0% over the past 30 days, after the insider's prior sales in early January showed strong near-term performance (30-day returns of +9.0% to +10.2%). The company remains unprofitable (net income of $-4,072,000.00 in the latest quarter) and carries a very elevated P/E of 261.11, indicating limited traditional earnings support for valuation. Investors should note that this transaction reflects a derivative conversion per Form 4 Table II, and the true post-conversion position extends beyond the Table I share count of 24,089 shares.

Co-CEO Gilboa David Abraham sold 375,000 shares in 3 transactions (blended $25.17) for $9.4M, retaining 12,306 shares post-sale.

David Abraham, Co-Chief Executive Officer of Warby Parker, sold 375,000 shares across 3 separate transactions on 2025-01-02 and 2025-01-03 at prices between $25.14 and $25.41, generating $9,437,514.92 in proceeds and reducing his holdings from 387,306 shares to 12,306 shares (a 96.8% reduction in stake). The filing contains a derivative-conversion transaction, meaning the Form 4 Table I shares represent only part of his actual position. The blended sale price of $25.17 compares to a current price of $26.34 (0.4% below the 52-week high), and the stock has appreciated 10.7% over 30 days and 61.3% over 90 days—suggesting the January sales preceded a strong rally. His prior trades at WRBY show mixed outcomes: the most recent measurable outcome (2024-12-03 sale) posted a +12.1% return over 30 days, but his cross-ticker history shows only 28.57% well-timed rate at the 90-day mark, indicating marginal timing accuracy. The company remains unprofitable (net income of $-4.1M in the latest quarter and negative full-year net income), though revenues are growing at 12.0% annually, positioning the stock near multi-month highs during a period of recent insider selling by leadership.